Painchek Ltd (PCK) - Total Liabilities

Latest as of June 2025: AU$3.26 Million AUD ≈ $2.31 Million USD

Based on the latest financial reports, Painchek Ltd (PCK) has total liabilities worth AU$3.26 Million AUD (≈ $2.31 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PCK net asset momentum to track the company's year-over-year net asset growth rate.

Painchek Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Painchek Ltd's total liabilities have evolved over time, based on quarterly financial data. See Painchek Ltd (PCK) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Painchek Ltd Competitors by Total Liabilities

The table below lists competitors of Painchek Ltd ranked by their total liabilities.

Company Country Total Liabilities
Delta Resources Ltd
V:DLTA
Canada CA$743.51K
SeaStar Medical Holding Corporation
NASDAQ:ICU
USA $3.74 Million
Hanil Chemical Ind. Co. Ltd
KQ:007770
Korea ₩45.18 Billion
Vichitbhan Palmoil Public Company Limited
BK:VPO
Thailand ฿397.52 Million
Trivarx Ltd
AU:TRI
Australia AU$771.99K
Netel Holding AB
ST:NETEL
Sweden Skr1.78 Billion
Macompta Fr Sa
PA:MLMCA
France €1.38 Million
Prodigy Gold NL
AU:PRX
Australia AU$2.02 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Painchek Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Painchek Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.65 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.93 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.52 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Painchek Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Painchek Ltd (2011–2025)

The table below shows the annual total liabilities of Painchek Ltd from 2011 to 2025.

Year Total Liabilities Change
2025-06-30 AU$3.26 Million
≈ $2.31 Million
+12.82%
2024-06-30 AU$2.89 Million
≈ $2.05 Million
+35.95%
2023-06-30 AU$2.13 Million
≈ $1.51 Million
+16.30%
2022-06-30 AU$1.83 Million
≈ $1.29 Million
-48.72%
2021-06-30 AU$3.57 Million
≈ $2.52 Million
+70.88%
2020-06-30 AU$2.09 Million
≈ $1.48 Million
+232.12%
2019-06-30 AU$628.44K
≈ $444.66K
+40.31%
2018-06-30 AU$447.89K
≈ $316.91K
+116.13%
2017-06-30 AU$207.23K
≈ $146.63K
-79.87%
2016-06-30 AU$1.03 Million
≈ $728.47K
+19.71%
2015-06-30 AU$860.00K
≈ $608.50K
+452.12%
2014-06-30 AU$155.76K
≈ $110.21K
+61.08%
2013-06-30 AU$96.70K
≈ $68.42K
+162.96%
2012-06-30 AU$36.77K
≈ $26.02K
-36.87%
2011-06-30 AU$58.25K
≈ $41.22K
--

About Painchek Ltd

AU:PCK Australia Health Information Services
Market Cap
$15.53 Million
AU$21.95 Million AUD
Market Cap Rank
#25901 Global
#1148 in Australia
Share Price
AU$0.11
Change (1 day)
+5.00%
52-Week Range
AU$0.04 - AU$0.36
All Time High
AU$0.36
About

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more